XSHG
600750
Market cap2.30bUSD
Feb 24, Last price
24.85CNY
1Q
13.94%
Jan 2017
69.32%
Name
Jiang Zhong Pharmaceutical Co Ltd
Chart & Performance
P/E
20.04
P/S
3.56
EPS
1.24
Div Yield, %
4.81%
Shrs. gr., 5y
0.02%
Rev. gr., 5y
12.61%
Revenues
4.44b
+1.03%
Net income
788m
+11.28%
CFO
786m
-24.10%
Dividend
Oct 13, 20250.5 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiang Zhong Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of traditional Chinese medicine and health foods. The company offers OTC class products for gastrointestinal digestion, upper respiratory tract, and tonics; protein nutrition, tonics, health regimen, probiotics, daily protection, beauty, bone health, and plant liver protection health products; and prescription products. It sells its products under the Jiangzhong and Jianweixiaoshi brands. Jiang Zhong Pharmaceutical Co.,Ltd is based in Nanchang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||